TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Nova Eye Medical ( (AU:EYE) ) is now available.
Nova Eye Medical Limited reported a 32% increase in global sales, excluding China, for the quarter ending September 2025, with revenue reaching US$4.9 million. The company received approval from China’s National Medical Products Administration for its iTrack™ Advance product, which is expected to enhance its market presence in China. Despite slower-than-expected commercial expansion in the USA and Canada, the company reaffirmed its FY26 sales revenue guidance and is targeting improved cash flow and EBITDA breakeven by the second half of FY26.
More about Nova Eye Medical
Nova Eye Medical Limited is a medical technology company focused on developing advanced ophthalmic treatment technologies and devices.
Average Trading Volume: 301,365
Technical Sentiment Signal: Hold
Current Market Cap: A$44.86M
See more insights into EYE stock on TipRanks’ Stock Analysis page.